Skip to Main Content

Paper Details

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.
Acta Neuropathol
9
2023
CDKN2A, malignant, malignant meningiomas, p16
Author NameAffiliation
Kanish MirchiaUniversity of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
Joanna J PhillipsUniversity of California San Francisco
Arie PerryUniversity of California San Francisco
Arie PerryUniversity of California San Francisco
Arie PerryUniversity of California San Francisco
Arie PerryUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
David R RaleighUniversity of California San Francisco
Calixto-Hope G LucasUniversity of California San Francisco
Calixto-Hope G LucasJohns Hopkins University School of Medicine
Calixto-Hope G LucasUniversity of California San Francisco
Calixto-Hope G LucasJohns Hopkins University School of Medicine
David A SolomonUniversity of California San Francisco
David A SolomonUniversity of California San Francisco
  • 1 - 19

Datasets